Class information for:
Level 1: NICERGOLINE//SERMION//CAS 27848 84 6

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
30958 160 25.6 42%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
658 3       COENZYME Q10//UBIQUINONE//COENZYME Q 11100
2774 2             VINPOCETINE//NEFIRACETAM//PIRACETAM 3137
30958 1                   NICERGOLINE//SERMION//CAS 27848 84 6 160

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 NICERGOLINE authKW 2431820 18% 44% 29
2 SERMION authKW 429404 2% 75% 3
3 CAS 27848 84 6 authKW 254461 1% 67% 2
4 MARKET CO ITALY address 254461 1% 67% 2
5 SANDOZ CLINICAL ASSESSMENT GERIATRIC SCALE authKW 254461 1% 67% 2
6 17 C 14 NICERGOLINE authKW 190847 1% 100% 1
7 2 METHYL 6 P METHOXYPHENYL 3 7DIHYDROIMIDAZO1 2 APYRAZIN 3 ONE DEPENDENT CHEMILUMINESCENT METHOD authKW 190847 1% 100% 1
8 4 ACETYL 4 PHENYLPIPERIDINE authKW 190847 1% 100% 1
9 4 HYDROXY 4 PHENYLPIPERIDINE authKW 190847 1% 100% 1
10 5 HT2B AGONISM authKW 190847 1% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Pharmacology & Pharmacy 996 46% 0% 74
2 Geriatrics & Gerontology 293 8% 0% 12
3 Psychiatry 101 10% 0% 16
4 Chemistry, Medicinal 85 8% 0% 12
5 Cardiac & Cardiovascular System 70 9% 0% 15
6 Neurosciences 37 11% 0% 18
7 Clinical Neurology 30 8% 0% 12
8 Crystallography 13 3% 0% 5
9 Peripheral Vascular Diseases 10 3% 0% 5
10 Chemistry, Multidisciplinary 7 8% 0% 12

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 MARKET CO ITALY 254461 1% 67% 2
2 CNS MED DEV 190847 1% 100% 1
3 MARKET CO ITALY MED 190847 1% 100% 1
4 MARKET CORP ITALY 190847 1% 100% 1
5 NEUROL C MONDINO IRCCS 190847 1% 100% 1
6 NEUROL IRCCS SANTA LUCIA 190847 1% 100% 1
7 BRAIN FUNCT INC 95422 1% 50% 1
8 PHARMACEUT MARKETING HEADQUARTERS 95422 1% 50% 1
9 COMMON USE IL MED 63614 1% 33% 1
10 GERBERA 23854 1% 13% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 JOURNAL DE PHARMACOLOGIE 27901 4% 2% 7
2 REVISTA BRASILEIRA DE MEDICINA 7786 1% 2% 2
3 RESEARCH COMMUNICATIONS IN PSYCHOLOGY PSYCHIATRY AND BEHAVIOR 2921 1% 1% 2
4 FOLIA PHARMACOLOGICA JAPONICA 2773 3% 0% 4
5 METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY 2631 4% 0% 6
6 DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 2540 3% 0% 5
7 ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE 2094 3% 0% 4
8 MEDECINE & CHIRURGIE DIGESTIVES 1851 1% 1% 1
9 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 1556 4% 0% 6
10 CLINICAL DRUG INVESTIGATION 1393 3% 0% 4

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 NICERGOLINE 2431820 18% 44% 29 Search NICERGOLINE Search NICERGOLINE
2 SERMION 429404 2% 75% 3 Search SERMION Search SERMION
3 CAS 27848 84 6 254461 1% 67% 2 Search CAS+27848+84+6 Search CAS+27848+84+6
4 SANDOZ CLINICAL ASSESSMENT GERIATRIC SCALE 254461 1% 67% 2 Search SANDOZ+CLINICAL+ASSESSMENT+GERIATRIC+SCALE Search SANDOZ+CLINICAL+ASSESSMENT+GERIATRIC+SCALE
5 17 C 14 NICERGOLINE 190847 1% 100% 1 Search 17+C+14+NICERGOLINE Search 17+C+14+NICERGOLINE
6 2 METHYL 6 P METHOXYPHENYL 3 7DIHYDROIMIDAZO1 2 APYRAZIN 3 ONE DEPENDENT CHEMILUMINESCENT METHOD 190847 1% 100% 1 Search 2+METHYL+6+P+METHOXYPHENYL+3+7DIHYDROIMIDAZO1+2+APYRAZIN+3+ONE+DEPENDENT+CHEMILUMINESCENT+METHOD Search 2+METHYL+6+P+METHOXYPHENYL+3+7DIHYDROIMIDAZO1+2+APYRAZIN+3+ONE+DEPENDENT+CHEMILUMINESCENT+METHOD
7 4 ACETYL 4 PHENYLPIPERIDINE 190847 1% 100% 1 Search 4+ACETYL+4+PHENYLPIPERIDINE Search 4+ACETYL+4+PHENYLPIPERIDINE
8 4 HYDROXY 4 PHENYLPIPERIDINE 190847 1% 100% 1 Search 4+HYDROXY+4+PHENYLPIPERIDINE Search 4+HYDROXY+4+PHENYLPIPERIDINE
9 5 HT2B AGONISM 190847 1% 100% 1 Search 5+HT2B+AGONISM Search 5+HT2B+AGONISM
10 ABSOLUTE X RAY STRUCTURE 190847 1% 100% 1 Search ABSOLUTE+X+RAY+STRUCTURE Search ABSOLUTE+X+RAY+STRUCTURE

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 WINBLAD, B , FIORAVANTI, M , DOLEZAL, T , LOGINA, I , MILANOV, IG , POPESCUB, DC , SOLOMON, A , (2008) THERAPEUTIC USE OF NICERGOLINE.CLINICAL DRUG INVESTIGATION. VOL. 28. ISSUE 9. P. 533-552 35 60% 20
2 SALETU, B , GARG, A , SHOEB, A , (2014) SAFETY OF NICERGOLINE AS AN AGENT FOR MANAGEMENT OF COGNITIVE FUNCTION DISORDERS.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - 23 66% 0
3 FIORAVANTI, M , NAKASHIMA, T , XU, J , GARG, A , (2014) A SYSTEMATIC REVIEW AND META-ANALYSIS ASSESSING ADVERSE EVENT PROFILE AND TOLERABILITY OF NICERGOLINE.BMJ OPEN. VOL. 4. ISSUE 7. P. - 15 54% 2
4 DAMULIN, IV , (2010) THERAPEUTIC POTENTIAL AND POSSIBILITIES OF USING OF SERMION (NICERGOLINE) IN NEUROLOGICAL PRACTICE.ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA. VOL. 110. ISSUE 12. P. 119 -122 11 79% 0
5 WINBLAD, B , CARFAGNA, N , BONURA, L , ROSSINI, BM , WONG, EHF , BATTAGLIA, A , (2000) NICERGOLINE IN DEMENTIA - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL.CNS DRUGS. VOL. 14. ISSUE 4. P. 267 -287 20 35% 6
6 EZAN, E , DELESTRE, L , LEGENDRE, S , RIVIERE, R , DOIGNON, JL , GROGNET, JM , (2001) IMMUNOASSAYS FOR THE DETECTION OF NICERGOLINE AND ITS METABOLITES IN HUMAN PLASMA.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 25. ISSUE 1. P. 123-130 9 69% 5
7 CARACI, F , CHISARI, M , FRASCA, G , CANONICO, PL , BATTAGLIA, A , CALAFIORE, M , BATTAGLIA, G , BOSCO, P , NICOLETTI, F , COPANI, A , ET AL (2005) NICERGOLINE, A DRUG USED FOR AGE-DEPENDENT COGNITIVE IMPAIRMENT, PROTECTS CULTURED NEURONS AGAINST BETA-AMYLOID TOXICITY.BRAIN RESEARCH. VOL. 1047. ISSUE 1. P. 30 -37 13 38% 14
8 NISHIDA, A , IWATA, H , KUDO, Y , KOBAYASHI, T , MATSUOKA, Y , KANAI, Y , ENDOU, H , (2004) NICERGOLINE ENHANCES GLUTAMATE UPTAKE VIA GLUTAMATE TRANSPORTERS IN RAT CORTICAL SYNAPTOSOMES.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 27. ISSUE 6. P. 817 -820 13 39% 7
9 CEJKA, J , KRATOCHVIL, B , CVAK, L , JEGOROV, A , (2005) CRYSTAL STRUCTURE OF 1-METHYL-10 ALPHA-METHOXY-9,10-DIHYDROLYSERGOL, C18H24N2O2.ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES. VOL. 220. ISSUE 2. P. 207-208 5 100% 0
10 CEJKA, J , KRATOCHVIL, B , CVAK, L , JEGOROV, A , (2005) CRYSTAL STRUCTURE OF 1-HYDROXYMETHYL-10 ALPHA-METHOXY-9,10-DIHYDROLYSERGOL, C18H24N2O3.ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES. VOL. 220. ISSUE 3. P. 351-352 4 100% 0

Classes with closest relation at Level 1



Rank Class id link
1 24164 NEFIRACETAM//DM 9384//CAS 77191 36 7
2 10229 ANIRACETAM//PIRACETAM//OXIRACETAM
3 36644 LAPAROSCOPIC ADNEXAL SURGERY//VAGINAL TRANSDUCER//AMC UMCG UWV VUMC
4 34845 LAMBDA WAVE//EYE FIXATION RELATED POTENTIALS//EYE FIXATION RELATED POTENTIAL EFRP
5 21154 CAS 17479 19 5//DECMER INTENS//DORSAL HAND VEIN
6 35167 CAS 10379 14 3//GLOBAL OUTCOMES HTA MANAGEMENT//KC INDUCED CYTOSOLIC FREE CALCIUM TRANSIENT
7 33267 ATTA UR RAHMAN NAT PROD DISCOVERY//UCSS//COMPUTAT MED CHEM
8 32892 BIFEMELANE HYDROCHLORIDE//BIFEMELANE//INDELOXAZINE HYDROCHLORIDE
9 23982 VINPOCETINE//VA 045//CAVINTON
10 35953 ISOPINOCAMPHONE//HYSSOPUS OFFICINALIS//HYSSOPUS OFFICINALIS L

Go to start page